Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
From Development to Place in Therapy of Lorlatinib for the Treatment of ALK and ROS1 Rearranged Non-Small Cell Lung Cancer (NSCLC).
Diagnostics (Basel). 2023 Dec 25;14(1):48. doi: 10.3390/diagnostics14010048.
Diagnostics (Basel). 2023.
PMID: 38201357
Free PMC article.
Review.
Cite
Cite